Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy

被引：1
|
作者：
Faraji, Farhoud [1 ]
Cohen, Ezra E. W. [2 ]
Guo, Theresa W. [1 ]
机构：
[1] UC San Diego Hlth, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr, Dept Otolaryngol Head & Neck Surg, La Jolla, CA USA
[2] UC San Diego Hlth, Dept Internal Med, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr,Div Hematol Oncol, La Jolla, CA USA
来源：
TRANSLATIONAL CANCER RESEARCH | 2023年 / 12卷 / 05期
关键词：
Immunotherapy; salvage surgery; head and neck squamous cell carcinoma (HNSCC); HUMAN-PAPILLOMAVIRUS; INVESTIGATORS CHOICE; COMORBIDITY INDEX; MUTATIONAL BURDEN; SURGICAL SALVAGE; PD-1; BLOCKADE; CHECKMATE; 141; OPEN-LABEL; SURVIVAL; CANCER;
D O I：
10.21037/tcr-23-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1353 / 1358
页数：6
相关论文
共 50 条
  • [1] Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Borel, Christian
    Jung, Alain C.
    Burgy, Mickael
    CANCERS, 2020, 12 (09) : 1 - 19
  • [2] Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Hsieh, Ronan W.
    Borson, Steven
    Tsagianni, Anastasia
    Zandberg, Dan P.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Immunotherapy in recurrent and or metastatic squamous cell carcinoma of the head and neck
    Saada-Bouzid, Esma
    Peyrade, Frederic
    Guigay, Joel
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 146 - 151
  • [4] Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
    Lasniska, Izabela
    Kolenda, Tomasz
    Teresiak, Anna
    Lamperska, Katarzyna M.
    Galus, Lukasz
    Mackiewicz, Jacek
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (03) : 290 - 303
  • [5] Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck
    Recchia, Francesco
    Candeloro, Giampiero
    Di Staso, Mario
    Necozione, Stefano
    Bisegna, Roberta
    Bratta, Massimo
    Tombolini, Vincenzo
    Rea, Silvio
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (04) : 413 - 419
  • [6] Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Greenhalgh, J.
    Bagust, A.
    Boland, A.
    Fleeman, N.
    McLeod, C.
    Dundar, Y.
    Proudlove, C.
    Shaw, R.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 49 - 54
  • [7] Optimizing Treatment for Head and Neck Cancers: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Haddad, Robert, I
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07): : 982 - 984
  • [8] The effect of opioids on the efficacy of immunotherapy in recurrent/ metastatic squamous cell carcinoma of the head and neck
    Scheff, Nicole N.
    Nilsen, Marci L.
    Li, Jinhong
    Harris, Alexandria L.
    Acharya, Rajesh
    Swartz, Andrew
    Hsieh, Ronan W.
    Anderson, Jennifer L.
    Ferris, Robert L.
    V. Menk, Ashley
    Delgoffe, Greg M.
    Zandberg, Dan P.
    ORAL ONCOLOGY, 2023, 140
  • [9] Alpelisib and Immunotherapy: A Promising Combination for Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
    Suleiman, Riham
    McGarrah, Patrick
    Baral, Binav
    Owen, Dawn
    Aguilera, Jesus Vera
    Halfdanarson, Thor R.
    Price, Katharine A.
    Bayne, Harry E. Fuentes
    CANCER REPORTS, 2024, 7 (10)
  • [10] Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Sacco, Assuntina G.
    Cohen, Ezra E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29) : 3305 - +
12345